The authors suggested that the HMGA2 oncoprotein plays a critical role in the pathogenesis of AT/RT development and reconstitution of let-7 miRNA may provide a novel therapeutic strategy for the treatment of AT/RT patients. Here, HMGA2 is linked to ataxia telangiectasia.